SalesJul 202610 min read184 words

Discovery calls for Series B companies: scaling without breaking

How Series B companies scale discovery calls across regions and teams without losing the discipline that made it work at Series A.

Series B is the stress test for discovery calls. What worked at fifteen people fails at fifty unless the operating rhythm is deliberate.

The Series B move is to separate the model owner from the operators. One senior human owns strategy, discovery-to-opportunity conversion, and the weekly review; a small team runs the machine.

Add a second geography or segment only when the first one is producing a defensible number for two full quarters. Not before.

Governance appears at Series B — that is fine, provided it accelerates rather than slows. The test is whether reviews still make decisions or just distribute updates.

The Series B failure mode of discovery calls is reading a script instead of running a diagnosis, amplified by headcount. Fix the root cause; do not paper over it with more people.

Compensation begins to matter now. Pay operators on discovery-to-opportunity conversion outcomes, not on effort. Effort-based comp at Series B produces theatre.

A well-run discovery calls function at Series B is the moat that survives to Series C. Companies that skip this discipline burn through raises trying to buy it back.

discovery callssales discoveryMEDDICdiscovery calls for series Bscaling GTM

Frequently asked questions

Sales — answered

How does discovery calls change at Series B?
Ownership separates from execution; operating rhythm gets more deliberate; governance appears.
When should we expand to a second region?
After the first region delivers two straight quarters of defensible discovery-to-opportunity conversion.
What compensation model works for discovery calls operators at Series B?
Outcome-linked on discovery-to-opportunity conversion, not activity-based.
What is the Series B stress point?
Reading a script instead of running a diagnosis, amplified by headcount. Fix the root, not the symptom.

Growth Broker editorial

Filed under sales

Up next

Discovery calls trends to watch in 2026

Read piece

Ready to broker your growth?

Book a Growth Call